Antibiotic utilisation in primary and revision total hip replacement patients: A registry linkage cohort study of 106 253 patients using the Australian Orthopaedic Association National Joint Replacement Registry
Authors:
- Richard N. de SteigerRSRichard N. de Steiger
- Nicole L. PrattNPNicole L. Pratt
- Aarti GulyaniAGAarti Gulyani
- Katherine M. DuszynskiKDKatherine M. Duszynski
- Maria C. InacioMIMaria C. Inacio
- Stephen E. GravesSGStephen E. Graves
- Paul N. SmithPSPaul N. Smith
- For the Improving Joint Replacement Outcomes in Australia using National Data Linkage Study Working GroupFGFor the Improving Joint Replacement Outcomes in Australia using National Data Linkage Study Working Group
Open Access
- 7 September 2022
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 32 (2) , 238-247
Abstract
Purpose Infection is a major complication following joint replacement (JR) surgery. However, little data exist regarding antibiotic utilisation following primary JR and how use changes with subsequent revision surgery. This study aimed to examine variation in antibiotic utilisation rates before and after hip replacement surgery in those revised for infection, revised for other reasons and those without revision. Methods This retrospective cohort analysis used linked data from the Australian Orthopaedic Association National Joint Replacement Registry and Australian Government Pharmaceutical Benefits Scheme. Patients were included if undergoing total hip replacement (THR) for osteoarthritis in private hospitals between 2002 and 2017. Three groups were examined: primary THR with no subsequent revision (n = 102 577), primary THR with a subsequent revision for reasons other than periprosthetic joint infection (PJI) (n = 3156) and primary THR with a subsequent revision for PJI (n = 520). Monthly antibiotic utilisation rates and prevalence rate ratios (PRRs) with 95% confidence intervals (CIs) were calculated in the 2 years pre- and post-THR. Results Prior to primary THR antibiotic utilisation was 9%-10%. After primary THR, antibiotic utilisation rates were higher among patients revised for PJI (PRR 1.69, 95% CI 1.60-1.79) compared to non-revised patients, while the utilisation rate was lower in patients revised for reasons other than infection (PRR 0.96, 95% CI 0.93-0.98). For those revised for infection, antibiotic utilisation post-revision surgery was two times higher than those revised for other reasons (PRR 2.16, 95% CI 2.08-2.23). Utilisation of injectable antibiotics including, vancomycin, flucloxacillin and cephazolin was higher in those revised for PJI patients 0-2 weeks following surgery but not in those revised for other reasons compared to the non-revised group. Conclusions Ongoing antibiotic utilisation after primary surgery may be an early signal of problems with the THR and should be a prompt for primary care physicians to refer patients to specialists for further appropriate investigations and management.Keywords
Funding Information
- Hospital Research Foundation
This publication has 16 references indexed in Scilit:
- Description of the rates, trends and surgical burden associated with revision for prosthetic joint infection following primary and revision knee replacements in England and Wales: an analysis of the National Joint Registry for England, Wales, Northern Ireland and the Isle of ManBMJ Open, 2017
- Increased Mortality After Prosthetic Joint Infection in Primary THAClinical Orthopaedics and Related Research, 2017
- Validation of the diagnosis ‘prosthetic joint infection’ in the Danish Hip Arthroplasty RegisterThe Bone & Joint Journal, 2016
- The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchersBMC Research Notes, 2015
- The “true” incidence of surgically treated deep prosthetic joint infection after 32,896 primary total hip arthroplastiesActa Orthopaedica, 2015
- Optimal Culture Incubation Time in Orthopedic Device-Associated Infections: a Retrospective Analysis of Prolonged 14-Day IncubationJournal of Clinical Microbiology, 2014
- AAOS Clinical Practice Guideline: Diagnosis and Treatment of Periprosthetic Joint Infections of the Hip and KneeJournal of the American Academy of Orthopaedic Surgeons, 2010
- Private sector treatment centres are treating less complex patients than the NHSJournal of the Royal Society of Medicine, 2010
- Case-mix & patients' reports of outcome in Independent Sector Treatment Centres: Comparison with NHS providersBMC Health Services Research, 2008
- Antibiotic prophylaxis in total hip arthroplastyEffects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty RegisterActa Orthopaedica, 2003